Congress:
ECR24
Poster Number:
C-23936
Type:
EPOS Radiologist (educational)
DOI:
10.26044/ecr2024/C-23936
Authorblock:
J. Goyal, N. Agarwal, P. Garg, S. K. Puri; NEWDELHI/IN
Disclosures:
Jitin Goyal:
Nothing to disclose
Nitin Agarwal:
Nothing to disclose
Prerna Garg:
Nothing to disclose
Sunil Kumar Puri:
Nothing to disclose
Keywords:
Gastrointestinal tract, Oncology, MR, Contrast agent-intravenous, Cancer
- Awiwi MO, Kaur H, Ernst R, Rauch GM, Morani AC, Stanietzky N, Palmquist SM, Salem UI. Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls. RadioGraphics. 2023 Mar 16;43(4):e220135.
- Kalisz KR, Enzerra MD, Paspulati RM. MRI evaluation of the response of rectal cancer to neoadjuvant chemoradiation therapy. Radiographics. 2019 Mar;39(2):538-56.
- Xu Q, Xu Y, Sun H, Jiang T, Xie S, Ooi BY, Ding Y. MRI evaluation of the complete response of locally advanced rectal cancer after Neoadjuvant therapy: Current status and future trends. Cancer Management and Research. 2021 Jun 1:4317-28.
- Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019 Mar;39(2):367-87.